Data / Drug companies / Ipg Pharmaceuticals, Inc.
Ipg Pharmaceuticals, Inc.: 12 products in the FDA NDC directory, labeler code 71085
Ipg Pharmaceuticals, Inc. (labeler code 71085) lists 12 products in the FDA National Drug Code Directory, covering 11 finished drugs by generic name. By type: 10 prescription drugs, 2 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 10, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71085
- Products in commercial distribution
- 12
- Packages
- 14
- Finished drugs by generic name
- 11
- Prescription products
- 10
- Over the counter products
- 2
- Flagged as original packager
- 6 of 6 products that carry the flag
- Started marketing in the last 12 months
- 8
- Products with a marketing end date set
- 1
- Earliest marketing start
- January 13, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 9 | 75% |
| New drug applications (NDA) | 2 | 16.7% |
| Over the counter monograph drugs | 1 | 8.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 10 | 83.3% |
| Over the counter drugs | 2 | 16.7% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Buspirone hydrochloride | 2 | 50 |
| Ketoconazole | 1 | 35 |
| Potassium chloride | 1 | 84 |
| Lidocaine | 1 | 216 |
| Lidocaine and tetracaine | 1 | 1 |
| Diclofenac sodium topical gel, 1% | 1 | 15 |
| Clemastine fumarate | 1 | 3 |
| Fluticasone propionate | 1 | 71 |
| Carbinoxamine maleate | 1 | 9 |
| Flurbiprofen | 1 | 3 |
| Tofacitinib | 1 | 23 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 4 | 33.3% |
| Cream | 3 | 25% |
| Solution | 2 | 16.7% |
| For solution | 1 | 8.3% |
| Gel | 1 | 8.3% |
| Spray, metered | 1 | 8.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ketoconazole | 71085-008 | Cream | Generic drugs (ANDA) | September 10, 2026 |
| Diclofenac sodium | 71085-084 | Gel | Generic drugs (ANDA) | September 6, 2026 |
| Tofacitinib | 71085-099 | Solution | Generic drugs (ANDA) | June 15, 2026 |
| Buspirone Hydrochloride | 71085-094 | Tablet | Generic drugs (ANDA) | May 29, 2026 |
| Buspirone Hydrochloride | 71085-093 | Tablet | Generic drugs (ANDA) | May 29, 2026 |
| Pliaglis | 71085-100 | Cream | New drug applications (NDA) | March 6, 2026 |
| Fluticasone Propionate | 71085-090 | Spray, metered | Generic drugs (ANDA) | March 6, 2026 |
| Potassium Chloride | 71085-083 | For solution | New drug applications (NDA) | December 1, 2025 |
| Lurbiro | 71085-082 | Tablet | Generic drugs (ANDA) | August 1, 2025 |
| Clemsza | 71085-081 | Tablet | Generic drugs (ANDA) | August 1, 2025 |
| Carbzah | 71085-080 | Solution | Generic drugs (ANDA) | June 1, 2025 |
| Lidocaine Cream, 4% | 71085-075 | Cream | Over the counter monograph drugs | January 13, 2025 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.